Tag: multiple sclerosis (ms)

Maternal Chronic Conditions Predict Cerebral Palsy in Offspring

Several maternal chronic conditions increase the risk of giving birth to a child with cerebral palsy, based on data from more than 1.3 million Norwegian...

Anti-CD20s Linked to Higher COVID-19 Severity in MS

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Like other people, patients with multiple sclerosis (MS) who become infected...

Certain DMTs in MS May Attenuate COVID-19 Vaccines

Dr Amit Bar-Or COVID-19 vaccines are considered safe for patients with multiple sclerosis (MS), a neurologist told colleagues, but those who are on disease-modifying therapy...

Sun Exposure Linked to Reduced Pediatric MS Risk

Children who have higher levels of sun exposure appear to have a substantially lower risk of developing pediatric multiple sclerosis (MS) than children who are...

Natalizumab Postinfusion Reactions Rare; Is Monitoring Necessary?

Reactions to the infusion of natalizumab (Tysabri) for the treatment of multiple sclerosis (MS) are very uncommon, are usually mild, and nearly always occur during,...

Vitamin D Deficiency Linked to Early Cognitive Impairment in MS

Vitamin D deficiency detected at the time of diagnosis of multiple sclerosis (MS) is associated with cognitive impairment and may also affect disability, according to...

Opioid Use Common for Pain in Multiple Sclerosis

With chronic pain common among people with multiple sclerosis (MS), approximately 20% of patients report opioid use ― despite warnings that the drugs are generally...

NfL Levels Linked to Worse Disability in Real-World MS

Elevations in serum neurofilament light chain levels (sNfL) in people with multiple sclerosis (MS) are significantly linked to worse neurologic function, clinical disability, and lower...

Accident Gives MS Doctor Insight Into Patients’ Lives

Editor’s note: The original text has been revised and updated. As Gavin Giovannoni, MBBCh, PhD, an esteemed British multiple sclerosis (MS) expert, set out for...

MS Bears No Effect on Certain Pregnancy Complications

Multiple sclerosis (MS) may not pose a higher risk for complications in pregnant women, according to a new study published online Feb. 3 in Neurology Clinical Practice....

Is the EDSS an Adequate Measure in Secondary Progressive MS?

Clinical trials enrolling patients with progressive multiple sclerosis (MS) commonly use the Expanded Disability Status Scale (EDSS), an instrument that looks at impairment across several...

Different MS Cognitive Phenotypes Could Help Guide Care

Researchers have developed a new classification of cognitive function for patients with multiple sclerosis (MS) that is based on the identification of five cognitive phenotypes....

Heavy Drinking by Teens May Affect White Matter Integrity

Heavy alcohol use in adolescence is linked to disruptions in white matter integrity, new research suggests. In a case control study of more than 400...

Study Finds AD Significantly Associated With Autoimmune Diseases

A diagnosis of atopic dermatitis in individuals ages 15 years or older, compared with controls without atopic dermatitis, was nearly twice as likely to be...

Vascular Comorbidity in MS Linked to Atrophy, Functional Decline

Vascular comorbidities, including diabetes and hypertension, are linked to significantly lower measures of neurologic function in people with multiple sclerosis (MS) vs patients without these...

COVID-19 Risks No Higher in Patients With Multiple Sclerosis

The risk of severe outcomes from COVID-19 infection in patients with multiple sclerosis seems to align with that seen in the general population, new US...

Serum NfL May Flag Subclinical Disease in Pregnant MS Patients

Among women with multiple sclerosis (MS), levels of serum neurofilament light (sNfL) are higher during pregnancy and the postpartum period. The increase in sNfL is...

Increased Risk of Severe COVID With Anti-B-Cell MS Drugs?

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Concerns are being raised over an increased risk of severe COVID-19...

Prior Autoimmunity Does Not Predict Adverse Events

There is no evidence to support the idea that previous autoimmunity before or after alemtuzumab treatment predicts subsequent rare but serious and possibly life-threatening autoimmune...

Lower Rituximab Dose as Effective, Safer in MS

Further data suggesting that a lower dose of rituximab seems to offer similar effectiveness with a better safety profile than higher doses commonly used have...

Researchers Identify Five Cognitive Phenotypes in MS

Researchers have identified five cognitive phenotypes among patients with multiple sclerosis (MS). The lead researcher described the clinical characteristics and MRI findings unique to each...

Masitinib Impresses in ‘Nonactive’ Progressive MS

The investigational drug, masitinib (AB Science), which has a completely new mechanism of action for multiple sclerosis (MS), has shown a positive result in slowing...

Multiple Sclerosis Prodrome Holds Promise of Earlier Diagnosis

“It is time that the prodromal phase of multiple sclerosis is formally recognized.” That was the conclusion of Helen Tremlett, PhD, delivering the opening plenary...

Smoking Increases Risk of High Plasma NfL Levels in MS

A new study has found that patients with multiple sclerosis (MS) who smoke cigarettes regularly have an increased risk of higher plasma neurofilament light levels...

Lessons for Patients With MS and COVID-19

Two important lessons about managing patients with multiple sclerosis (MS) and COVID-19 have emerged from a hospital clinic in Madrid that managed COVID-infected patients with...